Orion OYJ Gross Profit 2017-2026 | ORINY

Orion OYJ annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.

Orion OYJ gross profit for the quarter ending March 31, 2026 was $0.297B, a 39.83% increase year-over-year.
Orion OYJ gross profit for the twelve months ending March 31, 2026 was $1.457B, a 38.57% increase year-over-year.
Orion OYJ annual gross profit for 2025 was $1.372B, a 34.01% increase from 2024.
Orion OYJ annual gross profit for 2024 was $1.024B, a 43.85% increase from 2023.
Orion OYJ annual gross profit for 2023 was $0.712B, a 20.4% decline from 2022.

Orion OYJ Annual Gross Profit (Millions of US $)
2025	$1,372
2024	$1,024
2023	$712
2022	$894
2021	$702
2020	$744
2019	$709
2018	$696
2017	$728
2016	$721

Orion OYJ Quarterly Gross Profit (Millions of US $)
2026-03-31	$297
2025-12-31	$581
2025-09-30	$297
2025-06-30	$282
2025-03-31	$213
2024-12-31	$284
2024-09-30	$351
2024-06-30	$204
2024-03-31	$185
2023-12-31	$190
2023-09-30	$186
2023-06-30	$167
2023-03-31	$168
2022-12-31	$167
2022-09-30	$358
2022-06-30	$185
2022-03-31	$185
2021-12-31	$175
2021-09-30	$154
2021-06-30	$187
2021-03-31	$186
2020-12-31	$171
2020-09-30	$170
2020-06-30	$210
2020-03-31	$193
2019-12-31	$180
2019-09-30	$197
2019-06-30	$169
2019-03-31	$164
2018-12-31	$184
2018-09-30	$143
2018-06-30	$186
2018-03-31	$184
2017-12-31	$201
2017-09-30	$159
2017-06-30	$181
2017-03-31	$187
2016-12-31	$302

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$10.723B	$2.137B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.845B	31.38
UCB SA (UCBJY)	Belgium	$60.713B	0.00
Takeda Pharmaceutical (TAK)	Japan	$57.538B	11.30
Zoetis (ZTS)	United States	$49.577B	18.36
Sandoz Group AG (SDZNY)	Switzerland	$37.136B	0.00
Otsuka Holdings, - (OTSKY)	Japan	$36.393B	14.73
BeOne Medicines - (ONC)	Switzerland	$33.976B	83.02
Daiichi Sankyo, - (DSNKY)	Japan	$33.284B	16.12
Astellas Pharma (ALPMY)	Japan	$29.805B	11.68
United Therapeutics (UTHR)	United States	$25.058B	20.49
Shionogi (SGIOY)	Japan	$18.069B	13.97
Merck (MKKGY)	Germany	$16.944B	11.65
IPSEN (IPSEY)	France	$16.273B	0.00
Summit Therapeutics (SMMT)	United States	$15.264B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.936B	27.96
Ionis Pharmaceuticals (IONS)	United States	$12.417B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.920B	0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$11.749B	16.23
Eisai (ESAIY)		$9.158B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.834B	16.35
Centessa Pharmaceuticals (CNTA)	United Kingdom	$6.102B	0.00
Grifols, S.A (GRFS)	Spain	$5.588B	0.00
Corcept Therapeutics (CORT)	United States	$4.458B	51.11
Crinetics Pharmaceuticals (CRNX)	United States	$4.130B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.094B	22.53
NewAmsterdam Pharma (NAMS)	Netherlands	$3.997B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.945B	16.50
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$3.838B	0.00
Indivior Pharmaceuticals (INDV)	United States	$3.724B	12.41
Hypermarcas (HYPMY)	Brazil	$3.308B	13.82
Dyne Therapeutics (DYN)	United States	$3.086B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.046B	9.86
Oruka Therapeutics (ORKA)	United States	$2.952B	0.00
Soleno Therapeutics (SLNO)	United States	$2.717B	228.83
Enliven Therapeutics (ELVN)	United States	$2.710B	0.00
Relay Therapeutics (RLAY)	United States	$2.670B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.479B	41.65
BioCryst Pharmaceuticals (BCRX)	United States	$2.398B	7.19
Nektar Therapeutics (NKTR)	United States	$2.223B	0.00
Definium Therapeutics (DFTX)	United States	$2.147B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.096B	19.46
Ocular Therapeutix (OCUL)	United States	$1.914B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.808B	0.00
Ardelyx (ARDX)	United States	$1.516B	0.00
Harrow (HROW)	United States	$1.338B	79.84
Savara (SVRA)	United States	$1.158B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.149B	5.37
Xeris Biopharma Holdings (XERS)	United States	$1.009B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.993B	0.00
Cronos Group (CRON)	Canada	$0.971B	0.00
Evotec AG (EVO)	Germany	$0.935B	0.00
Xencor (XNCR)	United States	$0.911B	0.00
Aktis Oncology (AKTS)	United States	$0.901B	0.00
Theravance Biopharma (TBPH)	United States	$0.842B	21.80
ARS Pharmaceuticals (SPRY)	United States	$0.799B	0.00
Relmada Therapeutics (RLMD)	United States	$0.765B	0.00
Bioventus (BVS)	United States	$0.753B	13.32
Ironwood Pharmaceuticals (IRWD)	United States	$0.592B	15.78
ProKidney (PROK)	United States	$0.589B	0.00
Esperion Therapeutics (ESPR)	United States	$0.557B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.556B	9.19
Rigel Pharmaceuticals (RIGL)	United States	$0.540B	4.49
Lyell Immunopharma (LYEL)	United States	$0.522B	0.00
Larimar Therapeutics (LRMR)	United States	$0.504B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.501B	0.00
Aquestive Therapeutics (AQST)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.487B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	21.37
Lexeo Therapeutics (LXEO)	United States	$0.443B	0.00
Altimmune (ALT)	United States	$0.422B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.409B	37.99
Century Therapeutics (IPSC)	United States	$0.404B	0.00
Akebia Therapeutics (AKBA)	United States	$0.375B	0.00
USANA Health Sciences (USNA)	United States	$0.334B	9.43
AleAnna (ANNA)	United States	$0.333B	124.75
Surrozen (SRZN)	United States	$0.324B	0.00
Siga Technologies (SIGA)	United States	$0.312B	14.06
Avalo Therapeutics (AVTX)	United States	$0.311B	0.00
Organogenesis (ORGO)	United States	$0.306B	8.81
Silence Therapeutics (SLN)	United Kingdom	$0.271B	0.00
Cybin (HELP)	Canada	$0.270B	0.00
Protara Therapeutics (TARA)	United States	$0.268B	0.00
Prelude Therapeutics (PRLD)	United States	$0.257B	0.00
Minerva Neurosciences (NERV)	United States	$0.238B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.230B	0.00
MediWound (MDWD)	Israel	$0.229B	0.00
Context Therapeutics (CNTX)	United States	$0.229B	0.00
Enlivex (ENLV)	Israel	$0.228B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.224B	0.00
Profound Medical (PROF)	Canada	$0.216B	0.00
OmniAb (OABI)	United States	$0.213B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.186B	0.00
Korro Bio (KRRO)	United States	$0.183B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.174B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.167B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.167B	0.00
Heron Therapeutics (HRTX)	United States	$0.161B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.154B	0.00
Avita Medical (RCEL)	United States	$0.154B	0.00
VAXART, INC (VXRT)	United States	$0.152B	10.50
Galectin Therapeutics (GALT)	United States	$0.151B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.147B	0.00
Journey Medical (DERM)	United States	$0.141B	0.00
Assertio Holdings (ASRT)	United States	$0.116B	0.00
Innate Pharma SA (IPHYF)	France	$0.115B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.107B	0.00
Pyxis Oncology (PYXS)	United States	$0.107B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Vivani Medical (VANI)	United States	$0.088B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.088B	0.00
PolyPid (PYPD)	Israel	$0.082B	0.00
Nuo Therapeutics (AURX)		$0.082B	0.00
Champions Oncology (CSBR)	United States	$0.080B	0.00
Gain Therapeutics (GANX)	United States	$0.076B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.073B	0.00
Fractyl Health (GUTS)	United States	$0.073B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.070B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
Dominari Holdings (DOMH)	United States	$0.065B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.049B	0.00
Nutriband (NTRB)	United States	$0.047B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.046B	34.33
SCYNEXIS (SCYX)	United States	$0.045B	0.00
Lite Strategy (LITS)	United States	$0.042B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.042B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Incannex Healthcare (IXHL)	Australia	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.033B	0.00
Tempest Therapeutics (TPST)	United States	$0.029B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
VYNE Therapeutics (VYNE)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Natural Alternatives (NAII)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Lipocine (LPCN)	United States	$0.016B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.014B	0.00
Wellgistics Health (WGRX)	United States	$0.014B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.014B	0.00
Scienture Holdings (SCNX)	United States	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Vivos Therapeutics (VVOS)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.012B	0.02
Ainos (AIMD)	United States	$0.012B	0.00
Cosmos Health (COSM)	United States	$0.011B	0.00
Mannatech (MTEX)	United States	$0.011B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
BioLineRx (BLRX)	Israel	$0.010B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.010B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.010B	0.00
Liminatus Pharma (LIMN)	United States	$0.008B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.008B	0.00
Inotiv (NOTV)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Xenetic Biosciences (XBIO)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.004B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.002B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
CDT Equity (CDT)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00